Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Update save search
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
IKT | $2.1 0.19% 52K
|
Health Technology
|
| O: 0.95%
H: 0.47%
C: -3.77%
update therapeutics development
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-04-18 (Crawled : 05:00) - globenewswire.com
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
| Email alert
Add to watchlist
year update therapeutics financial results
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: -2.15%
H: 1.24%
C: -7.15%
update pipeline therapeutics
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ALRN | $4.785 -4.3% -4.49% 85K
|
Health Technology
|
| O: -9.95%
H: 3.18%
C: 0.19%
business year update therapeutics financial results
Aptevo Therapeutics Provides Pipeline Update
Published: 2024-04-10 (Crawled : 14:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: -6.44%
H: 1.64%
C: -21.31%
update pipeline therapeutics
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
Published: 2024-04-08 (Crawled : 12:00) - biospace.com/
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
update cell nurown program therapeutics
NeuroSense Announces Year End 2023 Financial Results and Provides Business Update
Published: 2024-04-05 (Crawled : 13:30) - prnewswire.com
NRSN | $1.435 -5.59% -5.92% 120K
|
|
| O: 3.4%
H: 5.16%
C: -20.19%
business year update financial results
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
CYTO | $1.5 -7.95% 46K
|
Manufacturing
|
| O: 4.21%
H: 5.56%
C: 5.56%
business year update therapeutics financial results
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
ACHL | $0.7827 -2.16% -2.21% 200K
|
Manufacturing
|
| O: -16.22%
H: 0.99%
C: -7.89%
first melanoma update therapeutics advanced
TransCode Therapeutics Reports 2023 Results; Provides Business Update
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: -1.04%
H: 1.48%
C: -3.7%
business update therapeutics
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
QNCX | $1.06 0.0% 97K
|
Professional, Scientific, and T...
|
| O: 7.55%
H: 0.0%
C: -4.39%
business update therapeutics financial results
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: 6.27%
H: 21.97%
C: 21.59%
year update cell therapeutics financial results
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
Published: 2024-03-29 (Crawled : 12:00) - globenewswire.com
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
| Email alert
Add to watchlist
business update therapeutics financial results
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Published: 2024-03-28 (Crawled : 21:00) - globenewswire.com
APLT A | $4.4 -7.17% -7.73% 2.9M
|
Health Technology
| Email alert
Add to watchlist
fda update treatment pdufa therapeutics
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
UNCY | $1.08 -0.92% -0.93% 230K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
business year update financial results
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
VVOS | $2.72 2.26% 2.21% 34K
|
Health Technology
| Email alert
Add to watchlist
NVST | $19.96 1.06% 0.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
year update therapeutics financial results
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
CADL | $5.17 -5.31% -5.61% 520K
|
| Email alert
Add to watchlist
can-3110 drug presentation update trial therapeutics glioblastoma
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
OMGA | $2.4 -0.83% -0.83% 400K
|
|
| O: 1.41%
H: 4.72%
C: 1.39%
year update therapeutics financial results
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
FDMT M | $25.29 2.06% 2.02% 630K
|
Health Technology
|
| O: -4.77%
H: 0.11%
C: -6.73%
update treatment fibrosis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.